Current position

Ray Dalio’s Lam Research Corp (LRCX) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2024Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares3.46MHighest verified quarter-end share count
Quarters reported7Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Lam Research Corp in Q4 2024. The reported position was increased and reduced across later filings. Bridgewater Associates, LP currently reports 938.22K shares. The latest verified filing showed: Sold 40.3% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 40.3% of the position−633.01K shares · 938.22K shares remained
Filing context

Quarter-end price $433.33 · Estimated holding basis $104.72

Q1 2026
Sold 48.3% of the position−1.47M shares · 1.57M shares remained
Filing context

Quarter-end price $213.66 · Estimated holding basis $104.72

Q4 2025
Sold 12.2% of the position−422.32K shares · 3.04M shares remained
Filing context

Quarter-end price $171.18 · Estimated holding basis $104.72

Q3 2025
Bought 111.4% more+1.83M shares · 3.46M shares reported after the change
Filing context

Quarter-end price $133.90 · Estimated holding basis $104.72

Q2 2025
Sold 16.4% of the position−321.46K shares · 1.64M shares remained
Filing context

Quarter-end price $97.34 · Estimated holding basis $72.23

Q1 2025
Sold 22.6% of the position−573.16K shares · 1.96M shares remained
Filing context

Quarter-end price $72.70 · Estimated holding basis $72.23

Portfolio importance

How important is Lam Research Corp in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight1.7%Q2 2026
Current rank#7of 997 reported positions
Peak portfolio weight1.9%Q4 2025
Best historical rank#4Q4 2025
At peak importanceQ4 2025
LRCX
1.9%
Largest holding
11.1%
Cross-investor discovery

Who else owns Lam Research Corp?

Also reported by 4 other tracked investors in their latest verified filings.

Chase ColemanTiger Global Management LLC
LRCX5.7% of reported portfolio
David TepperAppaloosa LP
LRCX2.2% of reported portfolio
Stanley DruckenmillerDuquesne Family Office
LRCX0.4% of reported portfolio
Explore Lam Research Corp across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$288.112026-09-18

Market context only; not an investor transaction price.

Latest filing quarter-end price$433.33Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$104.72Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.